214 related articles for article (PubMed ID: 12682264)
21. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13.
Kumagai N; Fukuda K; Ishimura Y; Nishida T
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1448-53. PubMed ID: 10798661
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast.
Rokudai A; Terui Y; Kuniyoshi R; Mishima Y; Mishima Y; Aizu-Yokota E; Sonoda Y; Kasahara T; Hatake K
Biol Pharm Bull; 2006 Jun; 29(6):1102-9. PubMed ID: 16755001
[TBL] [Abstract][Full Text] [Related]
23. Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice.
Hisada T; Salmon M; Nasuhara Y; Chung KF
Am J Respir Crit Care Med; 1999 Aug; 160(2):571-5. PubMed ID: 10430730
[TBL] [Abstract][Full Text] [Related]
24. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6.
Hoeck J; Woisetschläger M
J Immunol; 2001 Sep; 167(6):3216-22. PubMed ID: 11544308
[TBL] [Abstract][Full Text] [Related]
25. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
26. Histamine and serotonin stimulate eotaxin production by a human lung fibroblast cell line.
Sato E; Haniuda M; Numanami H; Ushiyama T; Tsukadaira A; Takashi S; Okubo Y; Koyama S
Int Arch Allergy Immunol; 2002; 128 Suppl 1():12-7. PubMed ID: 12065904
[TBL] [Abstract][Full Text] [Related]
27. Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways.
Negri J; Early SB; Steinke JW; Borish L
J Allergy Clin Immunol; 2008 May; 121(5):1232-7. PubMed ID: 18355910
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.
Stellato C; Matsukura S; Fal A; White J; Beck LA; Proud D; Schleimer RP
J Immunol; 1999 Nov; 163(10):5624-32. PubMed ID: 10553092
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts.
Yoshisue H; Kirkham-Brown J; Healy E; Holgate ST; Sampson AP; Davies DE
J Allergy Clin Immunol; 2007 Jan; 119(1):132-40. PubMed ID: 17208594
[TBL] [Abstract][Full Text] [Related]
30. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.
Sato E; Nelson DK; Koyama S; Hoyt JC; Robbins RA
Antimicrob Agents Chemother; 2001 Feb; 45(2):401-6. PubMed ID: 11158732
[TBL] [Abstract][Full Text] [Related]
31. Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation.
Miyamasu M; Nakajima T; Misaki Y; Izumi S; Tsuno N; Kasahara T; Yamamoto K; Morita Y; Hirai K
Cytokine; 1999 Oct; 11(10):751-8. PubMed ID: 10525313
[TBL] [Abstract][Full Text] [Related]
32. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.
Bandeira-Melo C; Sugiyama K; Woods LJ; Phoofolo M; Center DM; Cruikshank WW; Weller PF
J Immunol; 2002 May; 168(9):4756-63. PubMed ID: 11971026
[TBL] [Abstract][Full Text] [Related]
33. A functional study on CysLT(1) receptors in human eosinophils.
Ohshima N; Nagase H; Koshino T; Miyamasu M; Yamaguchi M; Hirai K; Yamamoto K; Fujisawa T; Nakagawa N; Kishikawa K; Morita Y
Int Arch Allergy Immunol; 2002 Sep; 129(1):67-75. PubMed ID: 12373000
[TBL] [Abstract][Full Text] [Related]
34. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts.
Hoeck J; Woisetschläger M
J Immunol; 2001 Apr; 166(7):4507-15. PubMed ID: 11254707
[TBL] [Abstract][Full Text] [Related]
35. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
Langdon C; Kerr C; Tong L; Richards CD
J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
[TBL] [Abstract][Full Text] [Related]
36. Allergen challenge-induced changes in bone-marrow responses to leukotriene D
Masid-de-Brito D; Vieira BM; de Souza CC; Silva F; Gaspar-Elsas MIC; Xavier-Elsas P
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):199-210. PubMed ID: 32122206
[No Abstract] [Full Text] [Related]
37. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts.
Zhou X; Hu H; Balzar S; Trudeau JB; Wenzel SE
J Immunol; 2012 Jun; 188(12):6046-54. PubMed ID: 22573806
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
39. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
40. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
